BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Institutional) - Abbott Vascular; Biotronik; Boston Scientific Corporation; Medtronic